Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Case Reports in Obstetrics and Gynecology|February 16, 2017
A Case of Malignant Melanoma of the Uterine Cervix with Disseminated Metastases throughout the Vaginal WallTomoko Noguchi, Nami Ota, Yasushi Mabuchi, et al.
Molecular and Clinical Oncology|October 15, 2021
Low-grade endometrial stromal sarcoma in a young woman diagnosed after resection of endometrial polyp-like lesions: A case reportHitomi Matsukawa, Nami Ota, Kaho Nishioka, et al.
Oncology Letters|March 29, 2020
Changes in the gene mutation profiles of circulating tumor DNA detected using CAPP-Seq in neoadjuvant chemotherapy-treated advanced ovarian cancerTomoko Noguchi, Kazuko Sakai, Naoyuki Iwahashi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|October 18, 2007
[A case of elderly metastatic breast cancer with a complete response to treatment with capecitabine and cyclophosphamide]Shinya Iida, Kiyonori Furukawa, Tadashi Yokoyama, et al.
International Journal of Clinical Oncology|March 10, 2026
Comprehensive circulating tumor DNA mutation profiling via CAPP-Seq liquid biopsy for cervical cancerNaoyuki Iwahashi, Tomoko Noguchi, Kazuko Sakai, et al.
BMC Cancer|April 23, 2025
Adeno-associated virus-clustered regularly interspaced short palindromic repeats/cas9‑mediated ovarian cancer treatment targeting PD-L1Tamaki Yahata, Saori Toujima, Izumi Sasaki, et al.
PNAS Nexus|February 6, 2023
Cytoplasmic p53 aggregates accumulated in p53-mutated cancer correlate with poor prognosisNaoyuki Iwahashi, Midori Ikezaki, Yoshihiro Komohara, et al.
Molecular and Clinical Oncology|October 15, 2021
Malignant melanoma treated with pembrolizumab during pregnancy: A case report and review of the literatureYuki Anami, Sawako Minami, Aya Kumegawa, et al.
Cancer Science|February 1, 2019
Programmed cell death ligand 1 disruption by clustered regularly interspaced short palindromic repeats/Cas9-genome editing promotes antitumor immunity and suppresses ovarian cancer progressionTamaki Yahata, Mika Mizoguchi, Akihiko Kimura, et al.
Melanoma Research|April 4, 2022
Clinicopathological features and programmed death-ligand 1 immunohistochemical expression in a multicenter cohort of uterine and ovarian melanomas: a retrospective study in Japan (KCOG-G1701s)Mitsutake Yano, Kaei Nasu, Masanori Yasuda, et al.
Pageof 2